LifeMD (LFMD) Director Joseph DiTrolio Receives Award of 35,000 Shares

What Happened
Joseph DiTrolio, a director of LifeMD, was granted 35,000 restricted shares on August 11, 2026. The Form 4 reports the acquisition price as $0 (grant/award, transaction code A), so the filing lists a $0 purchase value. This is a compensation award of restricted stock rather than an open‑market purchase or sale.

Key Details

• Transaction date: August 11, 2026. Form 4 filed August 13, 2026 (Accession 0000912282-26-001097).
• Transaction type: Grant / Award (Form 4 code A).
• Shares granted: 35,000; reported acquisition price: $0; reported total value: $0.
• Vesting: Grant vests on June 1, 2027 (footnote F1).
• Shares owned after transaction: Not specified in the information provided.
• Other notes: No 10b5-1 plan, tax‑withholding, or sale reported in this filing.

Context
Restricted share awards are a common form of executive/director compensation intended to align insiders with long‑term shareholder value; because these shares vest in the future, they are not an immediate market purchase signal. For retail investors, outright purchases (open‑market buys) often carry clearer sentiment signals than routine compensation grants.